Home › Funds › Velan Capital Investment Management LP › TARA

Velan Capital Investment Management LP position in TARA

PROTARA THERAPEUTICS INC · Health Care

Velan Capital Investment Management LP reported holding 2,844,652 shares of TARA (PROTARA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$8.7M, representing 8.28% of its reported portfolio and ranking #3 among its reported holdings. Velan Capital Investment Management LP has disclosed TARA holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)2.84M sh
Reported value held$8.68M
Portfolio Weight8.28%
First reportedQ2 2024
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Velan Capital Investment Management LP's TARA position evolved

Velan Capital Investment Management LP first disclosed a stake in TARA in Q2 2024 at 480,000 shares (US$998K). The position peaked in Q4 2025 at 2,834,652 shares, worth US$15.1M. Across 10 filings, Velan Capital Investment Management LP increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 2,844,652 shares valued at US$8.7M. Notable position changes include a 175% increase in Q4 2024 (shares fell 19% over the following quarter), a 28% increase in Q2 2025 (shares rose 44% over the following quarter), a 33% increase in Q4 2025 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 480.00K $998.40K New
Q3 2024 574.00K $1.05M Add
Q4 2024 1.58M $8.34M Add
Q1 2025 1.67M $7.10M Add
Q2 2025 2.14M $6.48M Add
Q3 2025 2.14M $9.30M Hold
Q4 2025 2.83M $15.11M Add
Q1 2026 2.83M $14.77M Hold
Q2 2026 2.84M $10.87M Hold
Q3 2026 2.84M $8.68M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TARA and 13F data

TARA (PROTARA THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in TARA — the largest reported positions include Rosalind Advisors, Inc. (US$7.3M), Sio Capital Management, LLC (US$6.1M), ACORN CAPITAL ADVISORS, LLC (US$5.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TARA

All TARA fund holders →

FAQ

How long has Velan Capital Investment Management LP held TARA?

Velan Capital Investment Management LP has disclosed TARA holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Velan Capital Investment Management LP's current position in TARA?

As of Q3 2026, Velan Capital Investment Management LP holds 2.84M shares of TARA (PROTARA THERAPEUTICS INC), valued at $8.68M, representing 8.28% of its reported portfolio and ranking #3.

Has Velan Capital Investment Management LP been buying or selling TARA?

In the latest 13F filing (Q3 2026), Velan Capital Investment Management LP held unchanged its position in TARA. The position peaked in Q4 2025 at 2.83M shares.

Which other funds hold TARA?

Other major institutional holders of TARA include Rosalind Advisors, Inc., Sio Capital Management, LLC, ACORN CAPITAL ADVISORS, LLC, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.